New Potomac Partners’s Amgen AMGN Stock Holding History

New Potomac Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$32.2K	Buy	+100	New	+$32.7K	0.02%	128
2020 Q4	–	Sell	-485	Closed	-$123K	–	66
2020 Q3	$123K	Sell	485 -60	-11%	-$14.9K	0.1%	69
2020 Q2	$129K	Sell	545 -30	-5%	-$6.84K	0.12%	72
2020 Q1	$117K	Sell	575 -4,390	-88%	-$959K	0.13%	69
2019 Q4	$1.2M	Sell	4,965 -360	-7%	-$79.4K	1.12%	39
2019 Q3	$1.03M	Sell	5,325 -140	-3%	-$26.9K	1.03%	42
2019 Q2	$1.01M	Sell	5,465 -320	-6%	-$57.3K	1.02%	41
2019 Q1	$1.1M	Sell	5,785 -285	-5%	-$54.4K	1.11%	41
2018 Q4	$1.18M	Buy	6,070 +60	+1%	+$11.7K	1.27%	39
2018 Q3	$1.25M	Buy	6,010 +74	+1%	+$14.6K	1.15%	42
2018 Q2	$1.1M	Sell	5,936 -15	-0.3%	-$2.65K	1.06%	40
2018 Q1	$1.01M	Buy	5,951 +65	+1%	+$11.9K	1%	41
2017 Q4	$1.02M	Buy	+5,886	New	+$1.04M	0.98%	43

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

New Potomac Partners's AMGN Position: Q3 2024 in Review

New Potomac Partners opened a new position in Amgen (AMGN) in Q3 2024: 100 shares worth $32.2K. The stake represents 0.02% of the portfolio and ranks #128 among its holdings. This is a return to the name: New Potomac Partners previously reported a position in AMGN as recently as Q3 2020.

New Potomac Partners first reported a position in AMGN in Q4 2017 and has held it in 13 quarters since. The position peaked at $1.25M in Q3 2018. 2,828 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.

New Potomac Partners held 100 shares of Amgen worth $32.2K as of Q3 2024.
Amgen was a new New Potomac Partners position in Q3 2024.
Amgen made up 0.02% of New Potomac Partners's portfolio in Q3 2024, its #128 holding.
New Potomac Partners first reported a position in Amgen in Q4 2017 and has held it in 13 quarters since.
New Potomac Partners's Amgen position peaked at $1.25M in Q3 2018.
2,828 funds tracked by Wall St. Rank held Amgen as of Q3 2024.

Based on New Potomac Partners's 13F filing for Q3 2024, filed 8 Nov 2024.